Abstract
Patients with cancer can be considered more vulnerable to COVID-19 infection with severe disease and higher mortality rate. This can be attributed to the weaker immune system as a consequence of the malignancy and its treatment. The present study was undertaken to estimate the rate of COVID-19 infection in cancer patients, assess the severity of COVID-19 infection and mortality in cancer patients while on anticancer therapy.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Annals of oncology : official journal of the European Society for Medical Oncology
Paper Title
Journal
Date
